Abstract
Hemodialysis patients were studied to identify secondary hyperparathyroidism. The presence of elevated intact parathyroid hormone level was analyzed in different age and gender groups. It was revealed that the secondary hyperparathyroidism often developed at a younger age. In the elder age group, it was significantly more likely to develop on the background of long-term presence on renal replacement therapy. Development of hyperparathyroidism does not depend on the patient’s gender identity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bikbov, B. T., & Tomilina, N. A. (2015). Zamestitel’naja terapija terminal’noj hronicheskoj pochechnoj nedostatochnosti v Rossiskoj Federacii v 1998–2013 gg.[Renal replacement therapy for ESRD in Russian Federation, 1998–2013]. Nefrologija i dializ [Nephrology and Dialysis], 13(1), 5–87.
Kidney Disease. Improving Global Outcomes (KDIGO) CKD- MBD Work Group. (2009). KDIGO clinical practice guideline for the diagnosis, evolution, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney International, 76(113), 1–130.
Cavalcante, M. C., Lamy, Z. C., Lamy Filhi, F., et al. (2013). Factors associated with the quality of life of adults subjected to hemodialysis in a city in northeast Brazil. J Bras Nephrol, 35(2), 79–86. doi:10.5935/0101-2800.20130014.
Finkelstein, F. O., Arsenault, K. L., Taveras, A., et al. (2012). Assessing and improving the health-related quality of life of patients with ESRD. Nature Reviews Nephrol, 8(12), 718–724.
Laurain, E., Ayav, C., Erpelding, M. L., Kessler, M., et al. (2014). Targets for parathyroid hormone in secondary hyperparathyroidism: is a “one-size-fits-all” approach appropriate? A prospective incident cohort study. DMC Nephrol, 15(1), 132. doi:10.1186/1471-2369-15-132.
Ermolenko, V. M., Volgina, G. V., Dobronravov, V. A., et al. (2010). Nacional’nye rekomendacii po mineral’nym i kostnym narushenijam pri hronicheskoj bolezni pochek. Rossijskoe dializnoe obshhestvo[National recommendations of mineral and bone disorders in patients with chronic renal disease, Russian Dialysis Society]. Nefrologija i dializ [Nephrology and Dialysis], 17(3), 33–51.
Dzhon T. Daugirdas, Piter Dzh.Blejk, Todd S. Ing. (2003). Rukovodstvo po dializu [Dialysis guideline] Izdatel’stvo «Triada» [publishing office «Triada»]. Twer.
Vetchinnikova, O. N. (2013). Giperparatireoz pri hronicheskoj bolezni pochek[Hyperparathyroidism in Chronic kidney disease]. Jeffektivnaja farmakoterapija [Effective medical treatment], 44, 26–39.
Acknowledgments
The work is performed according to the Russian Government Program of Competitive Growth of Kazan Federal University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vakhitova, R., Khasanova, M. & Damocev, V. Hyperparathyroidism in Hemodialysis Population of Patients in Various Age Groups. BioNanoSci. 6, 355–356 (2016). https://doi.org/10.1007/s12668-016-0235-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12668-016-0235-8